Lifeboat Foundation

The world recently acknowledged the power of alternative cancer treatments by awarding the 2018 Nobel Prize in Medicine to Dr. James P. Allison and Dr. Tasuku Honjo for their work in immunotherapy. More specifically on checkpoint inhibitor therapies.

Until recently many in the scientific community had dismissed immunotherapy as a viable cancer treatment. Nevertheless, Allison and Honjo persevered and their breakthrough has allowed for the classification of new drugs and treatments that may help patients have run out of options.

Ironically, while many in the mainstream are barely learning of immunotherapy, a hospital in Mexico, CHIPSA Hospital, has been working with these treatments for over 38 year and often under fire from public ridicule that their treatments are strange and ineffective.

Continue reading “Alternative Cancer Treatments Brought to Legitimacy at Scientific Forum in San Diego” »

O.o.

Official video for Life On Mars? by David Bowie.

Continue reading “David Bowie – Life On Mars? (Official Video)” »

Researchers create altered synthetic genome, in move with potential medical benefits.

“Thus, our data demonstrate the ability of multicellular organisms to survive long-term (tens of thousands of years) cryobiosis under the conditions of natural cryoconservation,” the researchers said in a study published in Doklady Biological Sciences.

As Northrop Grumman’s NG-11 Cygnus spacecraft flew high above in low Earth orbit, NASA astronauts at the Johnson Space Center recently completed testing and evaluation of the company’s Earth-based full-scale cislunar habitat mockup.

Designed to test the ergonomics, feature layout and functional compatibility with basic “day-in-the-life” astronaut tasks for potential long-term use as a part of the future Lunar Gateway in cislunar space, the habitat mockup necessarily incorporated all core elements that would eventually be needed by a four-person Orion crew: sleep stations, a galley, crew exercise equipment and of course accommodations for science, a robotics workstations and life support systems.

Continue reading “NASA, Northrop Grumman finish testing cislunar habitat mockup” »

Nicola Bagalà and Michael Nuschke take a look at the future of pensions and how the possible defeat of age-related diseases will affect them.

If you work in social security, it’s possible that your nightmares are full of undying elderly people who keep knocking on your door for pensions that you have no way of paying out. Tossing and turning in your bed, you beg for mercy, explaining that there’s just too many old people who need pensions and not enough young people who could cover for it with their contributions; the money’s just not there to sustain a social security system that, when it was conceived in the mid-1930s, didn’t expect that many people would ever make it into their 80s and 90s. Your oneiric persecutors won’t listen: they gave the country the best years of their lives, and now it’s time for the country to pay them their due.

When you wake up, you’re relieved to realize that there can’t be any such thing as people who have ever-worsening degenerative diseases yet never die from them, but that doesn’t make your problem all that better; you still have quite a few old people, living longer than the pension system had anticipated, to pay pensions to, and the bad news is that in as little as about 30 years, the number of 65+ people worldwide will skyrocket to around 2.1 billion, growing faster than all younger groups put together [1]. Where in the world is your institution going to find the budget?

Continue reading “The Future of Pensions” »

But they don’t. Instead, they are less likely to develop or die of this enigmatic disease. The same is true of elephants and dinosaurs’ living relatives, birds. Marc Tollis, an assistant professor in the School of Informatics, Computing, and Cyber Systems at Northern Arizona University, wants to know why.

Tollis led a team of scientists from Arizona State University, the University of Groningen in the Netherlands, the Center for Coastal Studies in Massachusetts and nine other institutions worldwide to study potential cancer suppression mechanisms in cetaceans, the mammalian group that includes whales, dolphins and porpoises. Their findings, which picked apart the genome of the humpback whale, as well as the genomes of nine other cetaceans, in order to determine how their cancer defenses are so effective, were published today in Molecular Biology and Evolution.

The study is the first major contribution from the newly formed Arizona Cancer and Evolution Center or ACE, directed by Carlo Maley under an $8.5 million award from the National Cancer Institute. Maley, an evolutionary biologist, is a researcher at ASU’s Biodesign Virginia G. Piper Center for Personalized Diagnostics and professor in the School of Life Sciences. He is a senior co-author of the new study.

Continue reading “How whales defy the cancer odds: Good genes” »

In a medical first, the children were treated with genetically engineered T-cells from another person.